Enriched analgesic efficacy studies: an assessment by clinical trial simulation

Area of Science:

• Clinical pharmacology
• Pharmaceutical research
• Biostatistics

Background:

• Enrichment strategies in clinical trials aim to enhance the demonstration of drug efficacy by selecting likely responders.
• Excluding poor responders before the double-blind phase is a common enrichment technique.

Purpose of the Study:

• To examine factors relevant to clinical trial design using enrichment strategies.
• To evaluate the impact of excluding poor responders on trial outcomes through simulation.

Main Methods:

• Clinical trial simulations were conducted for an analgesic trial with an enrichment phase (open-dose titration) followed by a placebo-controlled maintenance phase.
• Enrichment was assessed by excluding subjects with pain scores above a defined cutoff (4-7/10).
• A chronic pain patient database was used; correlation between treatment and placebo response was simulated at 0.25, 0.5, and 0.75.

Main Results:

• The likelihood of trial success varied from 50% to 95% based on the correlation between treatment and placebo effect (0.25 to 0.75).
• Lower cutoff pain scores were found to decrease recruitment efficiency.

Conclusions:

• Investigators must carefully consider the correlation between treatment effect and placebo response when designing clinical trials utilizing enrichment techniques.
• Optimizing enrichment strategies is crucial for successful clinical trial outcomes.